Mark Stevenson, Executive Vice President and Chief Operating Officer of Thermo Fisher Scientific Inc. (the “Company”), notified the Company of his decision to retire effective March 18, 2022
the Board of Directors of the Company appointed Gianluca Pettiti, currently Senior Vice President and President of the Company’s Specialty Diagnostics business, Executive Vice President, effective December 27, 2021.
the Board of Directors of the Company appointed Michel Lagarde, currently Executive Vice President, Executive Vice President and Chief Operating Officer, effective January 1, 2022.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Mark Stevenson retired as Executive Vice President and Chief Operating Officer at THERMO FISHER SCIENTIFIC INC..
Action
retired
Role
Executive Vice President and Chief Operating Officer
Exact text from the filing
Mark Stevenson, Executive Vice President and Chief Operating Officer of Thermo Fisher Scientific Inc. (the “Company”), notified the Company of his decision to retire effective March 18, 2022
Gianluca Pettiti was appointed as Executive Vice President at THERMO FISHER SCIENTIFIC INC..
Action
appointed
Role
Executive Vice President
Exact text from the filing
the Board of Directors of the Company appointed Gianluca Pettiti, currently Senior Vice President and President of the Company’s Specialty Diagnostics business, Executive Vice President, effective December 27, 2021.
Michel Lagarde was appointed as Executive Vice President and Chief Operating Officer at THERMO FISHER SCIENTIFIC INC..
Action
appointed
Role
Executive Vice President and Chief Operating Officer
Exact text from the filing
the Board of Directors of the Company appointed Michel Lagarde, currently Executive Vice President, Executive Vice President and Chief Operating Officer, effective January 1, 2022.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.